The company has a 40 year history in the paper making industry and considers that innovation is a priority – and allocates 5% of its turnover for R&D in order to develop new applications and novel chemistries for paper making and to anticipate the future requirements of this particular market.

CEO Robert Moor: "We have to anticipate the future requirements of paper making which is presently in transformation. To remain focused in the chemistry of this sector, our Center of Studies and Discoveries develops products and searches to innovate constantly”.

One of the main problems encounteredin the tissue making process is the presence of bad odours, often caused by residues of hexanal (or hexanaldehyde C6H120). SYNTHRO-STAB HE functions by interfering with the chemical reaction which releases the smell by blocking and the deactivating the catalysts of the reaction. Accordingt to the supplier, the product manufactured  at industrial site of Auzouer-en-Touraine in Indre et Loire and in Saint-Avold in Moselle, France, meets the requirements of the Food and Drug Administration (FDA) and the efficacy has been proven in a Robinson test.